# Sham Innovation Santé

> Sham Innovation Santé is a VC fund in Lyon backing Biotechnology and Medical Device. See 16 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Lyon, France
- Total investments: 16
- Last investment: May 2022
- Lead investor: 13%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/sham/
- Website: https://sham.fr/

Sham Innovation Santé is a VC fund in Lyon focused on Biotechnology and Medical Device. Sham Innovation Sante is an innovation capital vehicle controlled and held by Sham, a mutual insurer specialized in risk management for health care, social welfare and community health organizations. Advised by Turenne Capital, Sham Innovation Sante's mission is to support innovative businesses in the health care sector through the growth anddevelopment phases of their life cycle.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.7M–$4.8M |
| Series A | $5.7M–$74M |
| Series B | $9.9M–$80M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 6 | 38% |
| Medical Device | 5 | 31% |
| Medical | 4 | 25% |
| Health Care | 4 | 25% |
| Pharmaceutical | 3 | 19% |

16 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 5 | 31% |
| Series A | 3 | 19% |
| Seed | 2 | 13% |
| Venture - Series Unknown | 2 | 13% |
| Funding Round | 1 | 6% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Therapixel | Therapixel develops and commercializes AI-based software for breast cancer detection and characterization | $15.6M | Series B | May 12, 2022 |  |
| Germitec SAS | Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system. | $11.6M | Venture - Series Unknown | May 10, 2022 |  |
| Cairdac | Cairdac is a manufacturer of autonomous leadless pacing transcatheter system capable of powering the device with no battery-life limitation. | $18.8M | Series A | Mar 31, 2022 |  |
| Amolyt Pharma | Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism. | $80M | Series B | Sep 16, 2021 |  |
| Keenturtle | Keenturtle is a medtech that provides e-health solutions to enhance medical & economic field such as provision of health data. | $1.8M | Venture - Series Unknown | Aug 02, 2021 |  |
| Coave Therapeutics | Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases. | $38.9M | Series B | Jul 21, 2021 |  |
| Mablink Bioscience | Mablink Bioscience is a biotechnology company specialized in the development of a new class of cancer drugs, called Antibody Drug Conjugate (ADC). | $4.8M | Seed | Apr 27, 2021 |  |
| AbolerIS Pharma | AbolerIS Pharma aims to develop novel and unique therapeutic approaches to induce immune tolerance. | $2.7M | Seed | Nov 04, 2020 |  |
| Amolyt Pharma | Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism. | $73.5M | Series A | Jul 31, 2019 |  |
| CarThera | CarThera designs and develops innovative therapeutic ultrasound-based medical devices for treating brain disorders since.The company’s proprietary device called SonoCloud® is an intracranial ultrasound implant that temporarily opens the blood-brain barrier (BBB) and allows a significantly increased concentration of therapeutic molecules to reachthe brain. | $9.9M | Series B | Dec 12, 2018 |  |

10 of 16 investments shown.

## Co-investors
- [Sham](https://shizune.co/investors/profile/societe-hospitaliere-d-assurances-mutuelles-sham) — VC Fund, 7 deals together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 5 deals together
- [Omnes Capital](https://shizune.co/investors/profile/omnes-capital) — VC Fund, 4 deals together
- [Octalfa](https://shizune.co/investors/profile/octalfa) — VC Fund, 3 deals together
- [Pontifax](https://shizune.co/investors/profile/pontifax) — VC Fund, 3 deals together
- [BNP Paribas Développement](https://shizune.co/investors/profile/bnp-paribas-developpement) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Health Care Investors in France](https://shizune.co/investors/health-care-investors-france)
- [Health Care VC Funds in France](https://shizune.co/investors/health-care-vc-funds-france)
- [Biotechnology Investors in France](https://shizune.co/investors/biotechnology-investors-france)
- [Biotechnology VC Funds in France](https://shizune.co/investors/biotechnology-vc-funds-france)
- [Biotech Investors in France](https://shizune.co/investors/biotech-investors-france)
- [Biotech VC Funds in France](https://shizune.co/investors/biotech-vc-funds-france)

## FAQ

### What does Sham Innovation Santé invest in?

Sham Innovation Santé invests primarily in Biotechnology, Medical Device and Medical startups, most often at Series B and Series A stage. Most of the 16 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Sham Innovation Santé's check size?

Sham Innovation Santé typically joins rounds of $2.7M–$4.8M at Seed, $5.7M–$74M at Series A and $9.9M–$80M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sham Innovation Santé participates in.

### When did Sham Innovation Santé last invest?

The most recent investment recorded for Sham Innovation Santé closed in May 2022. Shizune tracks 16 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co